- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 38.08M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 46.99M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 46.24M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $28.5M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $23.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$122M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.7M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.58B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.04B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.23B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.04B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $1.39B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $1.28B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.21B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.31B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.26B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.85B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.11B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.17B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.16B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.27B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.33B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.49B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.83 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.85 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.96 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.88 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $92.6M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $83M |
| Net Income | Q1 2026 · Mar 31, 2026 | $37.5M |
| Net Income | Q1 2026 · Mar 31, 2025 | $38.4M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $72M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $75.2M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.01B |
| Revenue | Q1 2026 · Mar 31, 2025 | $915.5M |